Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Andrew Frankel , Shelley Zieroth , Aaron Wong , et al Added: 1 year ago
In this on-demand version of the live roundtable, cardiologists Dr Shelley Zieroth (University of Manitoba, Winnipeg, CA) and Dr Aaron Wong (Princess of Wales Hospital, Wales, UK) join nephrologists Dr Andrew Frankel (Imperial College Healthcare NHS Trust, London, UK), and Dr Manish Sood (University of Ottawa, CA) to discuss the nuanced landscape of RAASi management in cardiorenal patients.In… View more
Author(s): Andrew Frankel, Shelley Zieroth, Manish Sood ,et al Start date: Apr 15, 2024
Join cardiologists Dr Shelley Zieroth (University of Manitoba, Winnipeg, CA) and Dr Aaron Wong (Princess of Wales Hospital, Wales, UK) and nephrologists Dr Andrew Frankel (Imperial College Healthcare NHS Trust, London, UK), and Dr Manish Sood (University of Ottawa, CA) when they discuss the nuanced landscape of RAASi management in cardiorenal patients in this live roundtable.In this discussion,… View more
Author(s): Sunil V Rao Added: 11 months ago
Since the last update in 2013, what changes have been made to the new guidelines for managing acute coronary syndromes?In this short interview, Dr Sunil Rao (NYU Grossman School of Medicine, New York, US) discusses the new 2025 guideline for the management of acute coronary syndromes released by the AHA and ACC joint committee. The current guideline was informed by a number of clinical trials… View more
Author(s): Clara Bonanad Lozano , Anjay Rastogi Added: 1 year ago
Dr Anjay Rastogi (David Geffen School of Medicine UCLA, US) and Dr Clara Bonanad (University Clinical Hospital of Valencia, ES) discuss the evolving management strategies of hyperkalaemia in heart failure and chronic kidney disease, in this short video series. In this three part discussion they cover the most recent guidelines from ACC, ESC and KDIGO, real-world evidence from the recent ZORA… View more
Author(s): Robert A Byrne Added: 2 years ago
ESC 2023 — Dr Robert Byrne (Mater Private Hospital, Dublin, IE) joins us on-site to discuss the new guidelines from the ESC covering the management of acute coronary syndromes. Acute Coronary Syndrome (ACS) is a broad spectrum of conditions, and the presentation can vary from a stable patient, to a patient who is critically ill. In the past, separate guidelines were issued for ST-Elevation… View more
Research Area(s) / Expertise: Job title: Professor of Medicine
Dr Mikhail Kosiborod is a cardiologist based in the United States, where he serves as Senior Vice President, Late-stage Development, CVRM at AstraZeneca and Professor of Medicine at the University of Missouri–Kansas City. He is internationally recognised for his work at the intersection of cardiovascular disease, diabetes, and metabolic disorders, and has built a career that integrates clinical… View more
Dr Thomas Kahan is Senior consultant in cardiolgy at the Department of cardiology, Danderyd University Hospital Dr Kahan is on the Editorial Board of European Cardiology Review. Research Interests Neurohormonal control of blood pressure and cardiac function in man. Specifically, we study how the sympatho-adrenal mechanisms and the renin-angiotensin-aldosterone system influence… View more
Job title: Chief Scientific Officer, Clinical Cardiologist and Attending Physician
Personal HistoryDr Peter A McCullough was born in Buffalo, New York, on the 29th of December 1962. During high school, he and his family moved to Wichita Falls in Texas and later settled in Grapevine. He has lived and worked in various parts of the United States, including Washington and Michigan, and he now resides in Dallas, Texas.Academic HistoryDr McCullough attended Baylor University and… View more
Author(s): Javed Butler , Dinesh Khullar , John JV McMurray , et al Added: 3 months ago
In this expert-led webinar moderated by Dr Vijay Chopra, leading clinicians review current and emerging strategies in aldosterone modulation, hyperkalaemia management, and cardiorenal therapeutics.Dr Javed Butler opens with a practical overview of aldosterone’s central role in heart failure and CKD, emphasising the importance of achieving guideline-directed RAAS inhibitor and MRA dosing. He… View more
Research Area(s) / Expertise:

Heart Failure

Imaging & Diagnostics

Job title: Head of the Heart Transplant and Left Ventricular Device Program
Dr Kevin Damman is Head of the Heart Transplant and Left Ventricular Device Program at the University Medical Center Groningen in the Netherlands. His research interests focus on acute and advanced heart failure, including cardiorenal axis. He is also interested in improving the treatment of acute heart failure patients, with early assessment of decongestive therapies, SGLT2 inhibitors in… View more